Therapeutic strategies aimed at optimizing sleep architecture and its quality, including pharmacological, hormonal, and neuromodulatory interventions, may provide promising avenues for mitigating ED and promoting healthy ageing
Most patients run an initial protocol of three to six months before reassessment
On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight
Michael Davis, MD, Internal Medicine Physician, Wichita Clinic
One final point before we move on to questions and answers
Because of this shift, some patients may notice temporary irregular bleeding or spotting during the early weeks of treatment